|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6950 EUR | +14.50% |
|
+10.86% | -52.86% |
| 13/07 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 11/07 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.75% | -1.11% | +1.68% | +13.93% | +22.47% | +59.56% | +21.51% | +70.54% | +101.86% | 316B | |
| -0.92% | -0.07% | +1.54% | +31.16% | +18.27% | +34.38% | -9.40% | -23.02% | +46.61% | 73.28B | |
| +0.48% | +0.40% | +3.50% | +26.93% | +24.23% | +37.49% | +99.02% | +106.85% | +697.04% | 9.87B | |
| +0.10% | -7.59% | -7.85% | +2.53% | -2.87% | -4.29% | -6.23% | -29.27% | +44.47% | 8.15B | |
| +2.76% | +3.14% | -4.87% | -17.42% | -34.19% | -14.67% | -14.85% | -33.60% | - | 4.38B | |
| +0.40% | +6.22% | +6.68% | -17.02% | -33.19% | -33.30% | +7.29% | +40.45% | +82.49% | 3.91B | |
| +2.46% | +2.51% | -18.26% | +14.73% | +27.63% | -14.87% | +21.19% | -34.59% | - | 3.62B | |
| +9.47% | +1.33% | -0.11% | -4.07% | -5.05% | +25.74% | +46.33% | +77.47% | +104.20% | 2.51B | |
| -0.19% | +6.42% | +1.66% | -11.79% | -12.84% | -2.77% | -3.33% | +70.77% | - | 2.24B | |
| +1.75% | +0.63% | -4.84% | -12.68% | -6.40% | -24.72% | +29.50% | -32.98% | - | 1.76B | |
| -0.91% | +0.93% | -2.58% | -9.38% | -13.96% | -24.04% | -16.52% | -10.60% | -42.43% | 1.74B | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | |
| +0.59% | -4.07% | +21.44% | +51.97% | +173.03% | +213.44% | +1,629.21% | +683.87% | - | 1.26B | |
| -0.03% | +7.40% | -11.52% | -28.98% | -16.36% | -48.58% | -18.88% | - | - | 1.19B | |
| +4.60% | 0.00% | -5.01% | -37.61% | -36.85% | +51.13% | +41.72% | +23.52% | +464.30% | 1.17B | |
| +1.17% | -7.90% | -4.64% | -9.61% | -16.02% | -12.15% | +14.68% | +69.19% | +60.77% | 1.02B | |
| +4.21% | -3.34% | -32.17% | -10.13% | +4.21% | -13.36% | +73.68% | -8.20% | - | 1B | |
| -0.79% | +4.66% | +1.48% | -17.12% | -20.15% | -36.80% | -73.60% | -82.59% | - | 930M | |
| -2.89% | +11.07% | -3.17% | -34.63% | -25.66% | +9.27% | +4.19% | -0.15% | +168.80% | 928M | |
| Average | +1.23% | +2.13% | -3.17% | -3.84% | +2.57% | +11.19% | +102.53% | +52.22% | +172.81% | 22.99B | |
| Weighted average by Cap. | +0.56% | -1.82% | +1.18% | +15.46% | +19.54% | +49.71% | +21.39% | +51.77% | +105.40% |
- Stock Market
- Stocks
- AB Stock
- A8D Stock
- Sector AB Science
Select your edition
All financial news and data tailored to specific country editions
